E. J. Benjamin, P. Muntner, A. Alonso, M. S. Bittencourt, C. W. Callaway et al.,

K. Matsushita, A. E. Moran, M. E. Mussolino, M. O'flaherty, A. Pandey et al.,

, Update: A Report From the American Heart Association, Heart Disease and Stroke Statistics, vol.139, issue.10, pp.56-528, 2019.

P. K. Mehta and K. K. Griendling, Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system, Am J Physiol Cell Physiol, vol.292, issue.1, pp.82-97, 2007.

S. Dal-ros, C. Bronner, C. Auger, . Schini-kerth, and . Vb, Red wine polyphenols improve an established aging-related endothelial dysfunction in the mesenteric artery of middle-aged rats: role of oxidative stress, Biochem Biophys Res Commun, vol.419, issue.2, pp.381-388, 2012.
URL : https://hal.archives-ouvertes.fr/hal-00705029

S. Dal-ros, C. Bronner, C. Schott, M. O. Kane, M. Chataigneau et al.,

T. Chataigneau, Angiotensin II-induced hypertension is associated with a selective inhibition of endothelium-derived hyperpolarizing factor-mediated responses in the rat mesenteric artery, J Pharmacol Exp Ther, vol.328, issue.2, pp.478-86, 2009.

N. Idris-khodja, T. Chataigneau, C. Auger, . Schini-kerth, and . Vb, Grape-derived polyphenols improve aging-related endothelial dysfunction in rat mesenteric artery: role of oxidative stress and the angiotensin system, PLoS One, vol.7, issue.2, p.32039, 2012.

M. O. Kane, N. Etienne-selloum, S. V. Madeira, M. Sarr, A. Walter et al.,

T. Chataigneau, . Schini-kerth, and . Vb, Endothelium-derived contracting factors mediate the Ang References

B. Isomaa, P. Almgren, T. Tuomi, B. Forsen, K. Lahti et al., Cardiovascular morbidity and mortality associated with the metabolic syndrome, Diabetes care, vol.24, issue.4, pp.683-689, 2001.

D. E. Laaksonen, H. M. Lakka, L. K. Niskanen, G. A. Kaplan, J. T. Salonen et al., Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study, American journal of epidemiology, vol.156, issue.11, pp.1070-1077, 2002.

H. M. Lakka, D. E. Laaksonen, T. A. Lakka, L. K. Niskanen, E. Kumpusalo et al., The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men, Jama, vol.288, issue.21, pp.2709-2716, 2002.

C. Lorenzo, M. Okoloise, K. Williams, M. P. Stern, and S. M. Haffner, The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study, Diabetes care, vol.26, issue.11, pp.3153-3159, 2003.

S. Desroches and B. Lamarche, The evolving definitions and increasing prevalence of, vol.269, pp.845-850

H. G. Bohlen and J. M. Lash, Topical hyperglycemia rapidly suppresses EDRF-mediated vasodilation of normal rat arterioles. The American journal of physiology, vol.265, pp.219-225, 1993.

E. Vasile, Y. Tomita, L. F. Brown, O. Kocher, and H. F. Dvorak, Differential expression of thymosin beta-10 by early passage and senescent vascular endothelium is modulated by VPF/VEGF: evidence for senescent endothelial cells in vivo at sites of atherosclerosis, FASEB journal : official publication of the Federation of American Societies for Experimental Biology, vol.15, issue.2, pp.458-466, 2001.

T. Minamino, H. Miyauchi, T. Yoshida, Y. Ishida, H. Yoshida et al., Endothelial cell senescence in human atherosclerosis: role of telomere in endothelial dysfunction, Circulation, vol.105, issue.13, pp.1541-1544, 2002.

A. Kumar, C. S. Kim, T. A. Hoffman, A. Naqvi, J. Dericco et al.,

, Kruppel-Like Factor 2. Arteriosclerosis, thrombosis, and vascular biology, vol.31, pp.133-141, 2011.

B. Zinman, C. Wanner, J. M. Lachin, D. Fitchett, E. Bluhmki et al., Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes. The New England journal of medicine 2015, vol.373, pp.2117-2128

B. Neal, V. Perkovic, K. W. Mahaffey, D. De-zeeuw, G. Fulcher et al., Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes, vol.377, pp.644-657, 2017.

S. D. Wiviott, I. Raz, M. P. Bonaca, O. Mosenzon, E. T. Kato et al., Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes, The New England journal of medicine, vol.2019, issue.4, pp.347-357

M. Abbas, Endothelial Microparticles From Acute Coronary Syndrome Patients Induce Premature Coronary Artery Endothelial Cell Aging and Thrombogenicity: Role of the Ang II/AT1 Receptor/NADPH Oxidase-Mediated Activation of MAPKs and PI3-Kinase Pathways, Circulation ?, vol.135, issue.3, pp.280-296, 2017.

M. A. Abdul-ghani, R. A. Defronzo, and L. Norton, Novel Hypothesis to Explain Why SGLT2 Inhibitors Inhibit Only 30-50% of Filtered Glucose Load in Humans, Diabetes, vol.62, issue.10, pp.3324-3328, 2013.

A. Seif and A. M. , Efficacy and safety of canagliflozin compared to vildagliptin in treatment of experimentally induced diabetes in albino rats, vol.34, pp.80-80, 2017.

A. R. Aguillón, Synthetic Strategies toward SGLT2 Inhibitors, Organic Process Research & Development, vol.22, issue.4, pp.467-488, 2018.

S. Aker, Inhibition of the Na+/H+ exchanger attenuates the deterioration of ventricular function during pacing-induced heart failure in rabbits, Cardiovascular research, vol.63, issue.2, pp.273-282, 2004.

S. M. Albelda and C. A. Buck, Integrins and other cell adhesion molecules, FASEB journal : official publication of the Federation of American Societies for Experimental Biology, vol.4, issue.11, pp.2868-2880, 1990.

T. J. Anderson, Assessment and treatment of endothelial dysfunction in humans, Journal of the American College of Cardiology, vol.34, issue.3, pp.631-638, 1999.

T. J. Anderson, Systemic nature of endothelial dysfunction in atherosclerosis, The American Journal of Cardiology, vol.75, issue.6, pp.71-74, 1995.

H. Arai, Cloning and expression of a cDNA encoding an endothelin receptor, Nature, vol.348, issue.6303, pp.730-732, 1990.

I. A. Arenas, Angiotensin II-induced MMP-2 release from endothelial cells is mediated by TNF-alpha, AJP: Cell Physiology, vol.286, issue.4, pp.779-84, 2004.

H. Azumi, Superoxide generation in directional coronary atherectomy specimens of patients with angina pectoris: important role of NAD(P)H oxidase. Arteriosclerosis, thrombosis, and vascular biology, vol.22, pp.1838-1844, 2002.

A. Baartscheer, Na+]i and the driving force of the Na+/Ca2+-exchanger in heart failure, Cardiovascular research, vol.57, issue.4, pp.986-995, 2003.

A. Baartscheer, Chronic inhibition of Na+/H+-exchanger attenuates cardiac hypertrophy and prevents cellular remodeling in heart failure, Cardiovascular research, vol.65, issue.1, pp.83-92, 2005.

A. Baartscheer, Empagliflozin decreases myocardial cytoplasmic Na+ through inhibition of the cardiac Na+/H+ exchanger in rats and rabbits, Diabetologia, vol.60, issue.3, pp.568-573, 2017.

L. Badimon, Role of Platelet-Derived Microvesicles As Crosstalk Mediators in Atherothrombosis and Future Pharmacology Targets: A Link between Inflammation, Atherosclerosis, and Thrombosis, Frontiers in pharmacology, vol.7, p.293, 2016.

Z. Bagi, A. Koller, and G. Kaley, Superoxide-NO interaction decreases flow-and agonist-induced dilations of coronary arterioles in Type 2 diabetes mellitus, American journal of physiology. Heart and circulatory physiology, vol.285, issue.4, pp.1404-1414, 2003.

S. J. Bakker, Cytosolic triglycerides and oxidative stress in central obesity: the missing link between excessive atherosclerosis, endothelial dysfunction, and beta-cell failure?, Atherosclerosis, vol.148, issue.1, pp.17-21, 2000.

J. Balligand, O. Feron, and C. Dessy, eNOS activation by physical forces: from short-term regulation of contraction to chronic remodeling of cardiovascular tissues, Physiological Reviews, vol.89, issue.2, pp.481-534, 2009.

S. K. Banerjee, SGLT1 is a novel cardiac glucose transporter that is perturbed in disease states, Cardiovascular research, vol.84, issue.1, pp.111-118, 2009.

J. Bay, M. Kohlhaas, and C. Maack, Intracellular Na? and cardiac metabolism, Journal of Molecular and Cellular Cardiology, vol.61, pp.20-27, 2013.

R. Bergholm, Lowering of LDL cholesterol rather than moderate weight loss improves endothelium-dependent vasodilatation in obese women with previous gestational diabetes, Diabetes care, vol.26, issue.6, pp.1667-1672, 2003.

C. Berry, Investigation into the sources of superoxide in human blood vessels: angiotensin II increases superoxide production in human internal mammary arteries, Circulation ?, vol.101, issue.18, pp.2206-2212, 2000.

D. Bers, Excitation-contraction coupling and cardiac contractile force, vol.237, 2001.

E. Bertero and C. Maack, Calcium Signaling and Reactive Oxygen Species in Mitochondria, Circulation research, vol.122, issue.10, pp.1460-1478, 2018.

A. L. Betz, L. R. Drewes, and D. D. Gilboe, Inhibition of glucose transport into brain by phlorizin, phloretin and glucose analogues, Biochimica et biophysica acta, vol.406, issue.4, pp.505-515, 1975.

K. G. Birukov, Shear stress-mediated cytoskeletal remodeling and cortactin translocation in pulmonary endothelial cells, American journal of respiratory cell and molecular biology, vol.26, issue.4, pp.453-464, 2002.

T. Bombeli, M. Mueller, and A. Haeberli, Anticoagulant properties of the vascular endothelium, Thrombosis and haemostasis, vol.77, issue.3, pp.408-423, 1997.

C. Bonner, Inhibition of the glucose transporter SGLT2 with dapagliflozin in pancreatic alpha cells triggers glucagon secretion, Nature medicine, vol.21, issue.5, pp.512-517, 2015.

Y. C. Boo and H. Jo, Flow-dependent regulation of endothelial nitric oxide synthase: role of protein kinases, AJP: Cell Physiology, vol.285, issue.3, pp.499-508, 2003.

J. Bossuyt, Expression and phosphorylation of the na-pump regulatory subunit phospholemman in heart failure, Circulation research, issue.6, pp.558-565, 2005.

C. M. Boulanger, Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction, Circulation ?, vol.104, issue.22, pp.2649-2652, 2001.

S. W. Boyce, Impact of sodium-hydrogen exchange inhibition by cariporide on death or myocardial infarction in high-risk CABG surgery patients: results of the CABG surgery cohort of the GUARDIAN study, The Journal of thoracic and cardiovascular surgery, vol.126, issue.2, pp.420-427, 2003.

R. P. Brandes, An endothelium-derived hyperpolarizing factor distinct from NO and prostacyclin is a major endothelium-dependent vasodilator in resistance vessels of wild-type and endothelial NO synthase knockout mice, Proceedings of the National Academy of Sciences, vol.97, issue.17, pp.9747-9752, 2000.

K. Breitschopf, A. M. Zeiher, and S. Dimmeler, Pro-atherogenic factors induce telomerase inactivation in endothelial cells through an Akt-dependent mechanism, FEBS letters, vol.493, issue.1, pp.21-25, 2001.

S. V. Brodsky, Endothelium-derived microparticles impair endothelial function in vitro, American journal of physiology. Heart and circulatory physiology, vol.286, issue.5, pp.1910-1915, 2004.

G. K. Brown, Glucose transporters: structure, function and consequences of deficiency, Journal of inherited metabolic disease, vol.23, issue.3, pp.237-246, 2000.

M. Bucci, In vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide synthesis and reduces inflammation, Nature medicine, vol.6, issue.12, pp.1362-1367, 2000.

D. Bulut, Circulating endothelial microparticles correlate inversely with endothelial function in patients with ischemic left ventricular dysfunction, Journal of cardiac failure, vol.14, issue.4, pp.336-340, 2008.

D. Bulut, Selective cyclo-oxygenase-2 inhibition with parecoxib acutely impairs endothelium-dependent vasodilatation in patients with essential hypertension, Journal of hypertension, vol.21, issue.9, pp.1663-1667, 2003.

H. Cai and D. G. Harrison, Endothelial Dysfunction in Cardiovascular Diseases: The Role of Oxidant Stress, Circulation research, vol.87, issue.10, pp.840-844, 2000.

W. B. Campbell, Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors, Circulation research, vol.78, issue.3, pp.415-423, 1996.

C. P. Cannon, Design and baseline characteristics of the eValuation of ERTugliflozin effIcacy and Safety CardioVascular outcomes trial, 2018.

, American heart journal, vol.206, pp.11-23

T. M. Carlos and J. M. Harlan, Leukocyte-endothelial adhesion molecules, Blood, vol.84, issue.7, pp.2068-2101, 1994.

P. R. Casino, Impaired endothelium-dependent vascular relaxation in patients with hypercholesterolemia extends beyond the muscarinic receptor, The American Journal of Cardiology, vol.75, issue.1, pp.40-44, 1995.

P. R. Casino, The role of nitric oxide in endothelium-dependent vasodilation of hypercholesterolemic patients, Circulation ?, vol.88, issue.6, pp.2541-2547, 1993.

T. S. Cavaiola and J. Pettus, Cardiovascular effects of sodium glucose cotransporter 2 inhibitors. Diabetes, metabolic syndrome and obesity : targets and therapy, vol.11, pp.133-148, 2018.

A. J. Cayatte, Chronic inhibition of nitric oxide production accelerates neointima formation and impairs endothelial function in hypercholesterolemic rabbits, 1994.

, Arteriosclerosis and thrombosis : a journal of vascular biology, vol.14, pp.753-759

K. M. Channon, Oxidative stress and coronary plaque stability. Arteriosclerosis, thrombosis, and vascular biology, vol.22, pp.1751-1752, 2002.

T. Chataigneau, Acetylcholine-induced relaxation in blood vessels from endothelial nitric oxide synthase knockout mice, British journal of pharmacology, vol.126, issue.1, pp.219-226, 1999.

J. Chen, Contribution of p16INK4a and p21CIP1 pathways to induction of premature senescence of human endothelial cells: permissive role of p53, American journal of physiology. Heart and circulatory physiology, vol.290, issue.4, pp.1575-86, 2006.

J. Chen, Glycated collagen I induces premature senescence-like phenotypic changes in endothelial cells, Circulation research, vol.90, issue.12, pp.1290-1298, 2002.

J. Chen, Hypertension does not account for the accelerated atherosclerosis and development of aneurysms in male apolipoprotein e/endothelial nitric oxide synthase double knockout mice, Circulation ?, vol.104, issue.20, pp.2391-2394, 2001.

J. Chen, PREMATURE VASCULAR SENESCENCE IN METABOLIC SYNDROME: COULD IT BE PREVENTED AND REVERSED BY A SELENORGANIC ANTIOXIDANT AND PEROXYNITRITE SCAVENGER EBSELEN? Drug discovery today. Therapeutic strategies, vol.4, pp.93-99, 2007.

X. Chen, Antioxidant effects of vitamins C and E are associated with altered activation of vascular NADPH oxidase and superoxide dismutase in stroke-prone SHR, 2001.

T. Dallas, Hypertension, vol.38, issue.3, pp.606-611, 1979.

X. L. Chen, Angiotensin II induces monocyte chemoattractant protein-1 gene expression in rat vascular smooth muscle cells, Circulation research, vol.83, issue.9, pp.952-959, 1998.

Y. Cheng, Role of prostacyclin in the cardiovascular response to thromboxane A2, Science, issue.5567, pp.539-541, 2002.

J. Chiu and S. Chien, Effects of disturbed flow on vascular endothelium: pathophysiological basis and clinical perspectives, Physiological Reviews, vol.91, issue.1, pp.327-387, 2011.

H. E. Cingolani, The Anrep effect: 100 years later, American journal of physiology. Heart and circulatory physiology, vol.304, issue.2, pp.175-82, 2013.

R. A. Coleman, W. L. Smith, and S. Narumiya, International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes, Pharmacological reviews, vol.46, issue.2, pp.205-229, 1994.

J. P. Cooke, Flow activates an endothelial potassium channel to release an endogenous nitrovasodilator, The Journal of clinical investigation, vol.88, issue.5, pp.1663-1671, 1991.

J. Coppé, The senescence-associated secretory phenotype: the dark side of tumor suppression, Annual review of pathology, vol.5, issue.1, pp.99-118, 2010.

D. A. Cox and M. A. Matlib, A role for the mitochondrial Na (+)-Ca2+ exchanger in the regulation of oxidative phosphorylation in isolated heart mitochondria, Journal of Biological Chemistry, vol.268, issue.2, pp.938-947, 1993.

M. A. Creager, Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans, The Journal of clinical investigation, vol.86, issue.1, pp.228-234, 1990.

G. Cui, Amiloride attenuates lipopolysaccharide-accelerated atherosclerosis via inhibition of NHE1-dependent endothelial cell apoptosis, Acta pharmacologica Sinica, vol.34, issue.2, pp.231-238, 2013.

S. Dal-ros, Angiotensin II-induced hypertension is associated with a selective inhibition of endothelium-derived hyperpolarizing factor-mediated responses in the rat mesenteric artery, The Journal of pharmacology and experimental therapeutics, vol.328, issue.2, pp.478-486, 2009.

S. Dal-ros, Red wine polyphenols improve an established aging-related endothelial dysfunction in the mesenteric artery of middle-aged rats: role of oxidative stress, Biochemical and biophysical research communications, vol.419, issue.2, pp.381-387, 2012.
URL : https://hal.archives-ouvertes.fr/hal-00705029

M. De-gasparo, International union of pharmacology. XXIII. The angiotensin II receptors, Pharmacological reviews, vol.52, issue.3, pp.415-472, 2000.

L. De-koninck, Observations sur les proprieties febrifuges de las phloridzine, Bull Soc Med Gand, vol.1, pp.75-110, 1836.

G. De-nucci, Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor, Proceedings of the National Academy of Sciences of the United States of America, vol.85, issue.24, pp.9797-9800, 1988.

R. A. Defronzo, Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture, Diabetologia, vol.53, issue.7, pp.1270-1287, 2009.

R. A. Defronzo, L. Norton, and M. Abdul-ghani, Renal, metabolic and cardiovascular considerations of SGLT2 inhibition, Nature reviews. Nephrology, vol.13, issue.1, pp.11-26, 2017.

R. J. Dekker, Prolonged fluid shear stress induces a distinct set of endothelial cell genes, most specifically lung Krüppel-like factor (KLF2), Blood, vol.100, issue.5, pp.1689-1698, 2002.

S. Despa, Myocyte [Na+]i Dysregulation in Heart Failure and Diabetic Cardiomyopathy, Frontiers in physiology, vol.9, p.1303, 2018.

S. Despa, Intracellular Na(+) concentration is elevated in heart failure but Na/K pump function is unchanged, Circulation ?, issue.21, pp.2543-2548, 2002.

S. Despa, J. B. Lingrel, and D. M. Bers, Na(+)/K)+)-ATPase ?2-isoform preferentially modulates Ca2(+) transients and sarcoplasmic reticulum Ca2(+) release in cardiac myocytes, Cardiovascular research, vol.95, issue.4, pp.480-486, 2012.

D. L. Dewitt, Concentrations of prostaglandin endoperoxide synthase and prostaglandin I2 synthase in the endothelium and smooth muscle of bovine aorta, The Journal of clinical investigation, vol.72, issue.6, pp.1882-1888, 1983.

D. Franco and A. , Sodium-dependent glucose transporters (SGLT) in human ischemic heart: A new potential pharmacological target, International journal of cardiology, vol.243, pp.86-90, 2017.

M. Diamant, Cellular microparticles: new players in the field of vascular disease?, European journal of clinical investigation, vol.34, issue.6, pp.392-401, 2004.

G. P. Dimri, A biomarker that identifies senescent human cells in culture and in aging skin in vivo, Proceedings of the National Academy of Sciences, vol.92, issue.20, pp.9363-9367, 1995.

R. Doroudi, Effects of shear stress on eicosanoid gene expression and metabolite production in vascular endothelium as studied in a novel biomechanical perfusion model, Biochemical and biophysical research communications, vol.269, issue.1, pp.257-264, 2000.

W. Dröge, Free radicals in the physiological control of cell function, Physiological Reviews, vol.82, issue.1, pp.47-95, 2002.

V. J. Dzau, Significance of the vascular renin-angiotensin pathway, Hypertension, vol.8, issue.7, pp.553-559, 1979.

G. Edwards and A. H. Weston, Potassium and potassium clouds in endothelium-dependent hyperpolarizations. Endothelium-dependent hyperpolarizations, vol.49, pp.535-541, 2004.

H. Ehrenreich, Endothelins, peptides with potent vasoactive properties, are produced by human macrophages, The Journal of experimental medicine, vol.172, issue.6, pp.1741-1748, 1990.

M. El-daly, Hyperglycaemic impairment of PAR2-mediated vasodilation: Prevention by inhibition of aortic endothelial sodium-glucose-co-Transporter-2 and minimizing oxidative stress, Vascular pharmacology, vol.109, pp.56-71, 2018.

A. Ellis and C. R. Triggle, Endothelium-derived reactive oxygen species: their relationship to endothelium-dependent hyperpolarization and vascular tone, Canadian journal of physiology and pharmacology, vol.81, issue.11, pp.1013-1028, 2003.

S. Elmi, Sulfaphenazole treatment restores endothelium-dependent vasodilation in diabetic mice, Vascular pharmacology, vol.48, issue.1, pp.1-8, 2008.

S. Engelhardt, Inhibition of Na(+)-H(+) exchange prevents hypertrophy, fibrosis, and heart failure in beta(1)-adrenergic receptor transgenic mice, Circulation research, vol.90, issue.7, pp.814-819, 2002.

F. M. Faraci, Arachidonate dilates basilar artery by lipoxygenase-dependent mechanism and activation of K(+) channels, American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, vol.281, issue.1, pp.246-53, 2001.

M. Feletou and P. M. Vanhoutte, Endothelium-dependent hyperpolarization of canine coronary smooth muscle, British journal of pharmacology, vol.93, issue.3, pp.515-524, 1988.

M. Feletou and P. M. Vanhoutte, Endothelium-derived hyperpolarizing factor: where are we now? Arteriosclerosis, thrombosis, and vascular biology, vol.26, pp.1215-1225, 2006.

B. Feng, Circulating level of microparticles and their correlation with arterial elasticity and endothelium-dependent dilation in patients with type 2 diabetes mellitus, Atherosclerosis, vol.208, issue.1, pp.264-269, 2010.

B. Fisslthaler, Cytochrome P450 2C is an EDHF synthase in coronary arteries, Nature, vol.401, issue.6752, pp.493-497, 1999.

I. Fleming, Molecular mechanisms underlying the activation of eNOS. Pflügers Archiv : European journal of physiology, vol.459, pp.793-806, 2010.

M. J. Fowler, Microvascular and Macrovascular Complications of Diabetes, Clinical Diabetes, vol.26, issue.2, pp.77-82, 2008.

U. Förstermann and T. Münzel, Endothelial nitric oxide synthase in vascular disease: from marvel to menace, Circulation ?, vol.113, issue.13, pp.1708-1714, 2006.

H. Francois, A role for the thromboxane receptor in L-NAME hypertension, American journal of physiology. Renal physiology, vol.295, issue.4, pp.1096-102, 2008.

H. Francois, Role for thromboxane receptors in angiotensin-II-induced hypertension, Hypertension, vol.43, issue.2, pp.364-369, 1979.

H. S. Freitas, Na(+) -glucose transporter-2 messenger ribonucleic acid expression in kidney of diabetic rats correlates with glycemic levels: involvement of hepatocyte nuclear factor-1alpha expression and activity, Endocrinology, vol.149, issue.2, pp.717-724, 0201.

J. C. Frisbee, K. G. Maier, and D. W. Stepp, Oxidant stress-induced increase in myogenic activation of skeletal muscle resistance arteries in obese Zucker rats, American journal of physiology. Heart and circulatory physiology, vol.283, issue.6, pp.2160-2168, 2002.

R. F. Furchgott, Studies on relaxation of rabbit aorta by sodium nitrite: the basis for the proposal that the acid-activatable inhibitory factor from retractor penis is inorganic nitrite and the endothelium-derived relaxing factor is nitric oxide, pp.401-418, 1988.

R. F. Furchgott and J. V. Zawadzki, The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine, Nature, vol.288, issue.5789, pp.373-376, 1980.

A. Gabrielsen, Thromboxane synthase expression and thromboxane A2 production in the atherosclerotic lesion, Journal of molecular medicine, vol.88, issue.8, pp.795-806, 2010.

Z. S. Galis, Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques, The Journal of clinical investigation, vol.94, issue.6, pp.2493-2503, 1994.

Z. S. Galis, N-acetyl-cysteine decreases the matrix-degrading capacity of macrophage-derived foam cells: new target for antioxidant therapy?, Circulation ?, vol.97, issue.24, pp.2445-2453, 1998.

D. Garcia-dorado, Calcium-mediated cell death during myocardial reperfusion, Cardiovascular research, vol.94, issue.2, pp.168-180, 2012.

U. C. Garg and A. Hassid, Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells, The Journal of clinical investigation, vol.83, issue.5, pp.1774-1777, 1989.

T. Gaspari, Dapagliflozin attenuates human vascular endothelial cell activation and induces vasorelaxation: A potential mechanism for inhibition of atherogenesis, 2018.

, Diabetes & vascular disease research, vol.15, issue.1, pp.64-73

D. Gebremedhin, Bioassay of an endothelium-derived hyperpolarizing factor from bovine coronary arteries: role of a cytochrome P450 metabolite, Journal of vascular research, vol.35, issue.4, pp.274-284, 1998.

C. Ghezzi and E. M. Wright, Regulation of the human Na+-dependent glucose cotransporter hSGLT2, American journal of physiology. Cell physiology, vol.303, issue.3, pp.348-54, 2012.

D. M. Gilligan, Selective loss of microvascular endothelial function in human hypercholesterolemia, Circulation ?, vol.90, issue.1, pp.35-41, 1994.

M. A. Gimbrone, Endothelial Dysfunction, Hemodynamic Forces, and Atherosclerosis, Thrombosis and haemostasis, vol.82, issue.2, pp.722-726, 1999.

N. Gokce, Predictive value of noninvasivelydetermined endothelial dysfunction for long-term cardiovascular events inpatients with peripheral vascular disease, Journal of the American College of Cardiology, issue.10, pp.1769-1775, 2003.

T. Gori, Endothelium and haemorheology. Annali dell'Istituto superiore di sanita, vol.43, pp.124-129, 2007.

E. J. Griffiths, Mitochondrial calcium transport in the heart: physiological and pathological roles, Journal of Molecular and Cellular Cardiology, vol.46, issue.6, pp.789-803, 2009.

P. L. Gross and W. C. Aird, The endothelium and thrombosis. Seminars in thrombosis and hemostasis, vol.26, pp.463-478, 2000.

S. Gudi, J. P. Nolan, and J. A. Frangos, Modulation of GTPase activity of G proteins by fluid shear stress and phospholipid composition, Proceedings of the National Academy of Sciences, vol.95, issue.5, pp.2515-2519, 1998.

J. H. Han, The beneficial effects of empagliflozin, an SGLT2 inhibitor, on atherosclerosis in ApoE -/-mice fed a western diet, Diabetologia, vol.60, issue.2, pp.364-376, 2017.

Y. Han, SGLT inhibitors attenuate NO-dependent vascular relaxation in the pulmonary artery but not in the coronary artery, American journal of physiology. Lung cellular and molecular physiology, vol.309, issue.9, pp.1027-1063, 2015.

P. S. Hansen, Alloxan-induced diabetes reduces sarcolemmal Na+-K+ pump function in rabbit ventricular myocytes, AJP: Cell Physiology, vol.292, issue.3, pp.1070-1077, 2007.

D. G. Harrison, Interactions of angiotensin II with NAD(P)H oxidase, oxidant stress and cardiovascular disease, Journal of the renin-angiotensin-aldosterone system, vol.4, issue.2, pp.51-61, 2003.

T. Hayashi, Endothelial cellular senescence is inhibited by nitric oxide: implications in atherosclerosis associated with menopause and diabetes, Proceedings of the National Academy of Sciences of the United States of America, vol.103, pp.17018-17023, 2006.

W. G. Haynes and D. J. Webb, Contribution of endogenous generation of endothelin-1 to basal vascular tone, Lancet, issue.8926, pp.852-854, 1994.

C. He, AMPK Suppresses Vascular Inflammation In Vivo by Inhibiting Signal Transducer and Activator of Transcription-1, Diabetes, vol.64, issue.12, pp.4285-4297, 2015.

M. A. Hediger and D. B. Rhoads, Molecular physiology of sodium-glucose cotransporters, Physiological Reviews, vol.74, issue.4, pp.993-1026, 1994.

R. A. Hegele, The pathogenesis of atherosclerosis, Clinica chimica acta; international journal of clinical chemistry, vol.246, issue.1-2, pp.21-38, 1996.

T. Heitzer, Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease, Circulation ?, vol.104, issue.22, pp.2673-2678, 2001.

U. Hink, Mechanisms Underlying Endothelial Dysfunction in Diabetes Mellitus, Circulation research, vol.88, issue.2, pp.14-22, 2001.

G. Howard, Insulin sensitivity and atherosclerosis. The Insulin Resistance Atherosclerosis Study (IRAS) Investigators, Circulation ?, vol.93, issue.10, pp.1809-1817, 1996.

H. J. Hsieh, Increase of reactive oxygen species (ROS) in endothelial cells by shear flow and involvement of ROS in shear-induced c-fos expression, Journal of cellular physiology, vol.175, issue.2, pp.156-162, 1998.

P. L. Huang, Hypertension in mice lacking the gene for endothelial nitric oxide synthase, Nature, vol.377, issue.6546, pp.239-242, 1995.

B. Hugel, Membrane microparticles: two sides of the coin, Physiology, vol.20, issue.1, pp.22-27, 2005.

N. Idris-khodja, Grape-derived polyphenols improve aging-related endothelial dysfunction in rat mesenteric artery: role of oxidative stress and the angiotensin system, 2012.

C. Schulz, PloS one, vol.7, issue.2, p.32039

L. J. Ignarro, Heme-dependent activation of guanylate cyclase by nitric oxide: a novel signal transduction mechanism, vol.28, pp.67-73, 1991.

T. Imanishi, T. Hano, and I. Nishio, Angiotensin II accelerates endothelial progenitor cell senescence through induction of oxidative stress, Journal of hypertension, vol.23, issue.1, pp.97-104, 2005.

S. E. Inzucchi, Improvement in Cardiovascular Outcomes With Empagliflozin Is Independent of Glycemic Control, Circulation ?, vol.138, issue.17, pp.1904-1907, 2018.

K. Irani, Oxidant signaling in vascular cell growth, death, and survival : a review of the roles of reactive oxygen species in smooth muscle and endothelial cell mitogenic and apoptotic signaling, Circulation research, vol.87, issue.3, pp.179-183, 2000.

E. A. Jaffe, Cell biology of endothelial cells, Human pathology, vol.18, issue.3, pp.234-239, 1987.

F. Jiang, Angiotensin-converting enzyme 2 and angiotensin 1-7: novel therapeutic targets, Nature reviews. Cardiology, vol.11, issue.7, pp.413-426, 2014.

D. Kalra, N. Sivasubramanian, and D. L. Mann, Angiotensin II induces tumor necrosis factor biosynthesis in the adult mammalian heart through a protein kinase C-dependent pathway, Circulation ?, issue.18, pp.2198-2205, 2002.

M. O. Kane, Endothelium-derived contracting factors mediate the Ang II-induced endothelial dysfunction in the rat aorta: preventive effect of red wine polyphenols. Pflügers Archiv : European journal of physiology, vol.459, pp.671-679, 2010.
URL : https://hal.archives-ouvertes.fr/hal-00508221

M. Karmazyn, NHE-1: still a viable therapeutic target, Journal of Molecular and Cellular Cardiology, vol.61, pp.77-82, 2013.

K. Kauser, Role of endogenous nitric oxide in progression of atherosclerosis in apolipoprotein E-deficient mice, American journal of physiology. Heart and circulatory physiology, vol.278, issue.5, pp.1679-85, 2000.

L. M. Khachigian, Nuclear factor-kappa B interacts functionally with the platelet-derived growth factor B-chain shear-stress response element in vascular endothelial cells exposed to fluid shear stress, The Journal of clinical investigation, vol.96, issue.2, pp.1169-1175, 1995.

M. Khazaei, Effect of exercise on augmented aortic vasoconstriction in the db/db mouse model of type-II diabetes, Physiological research, vol.57, issue.6, pp.847-856, 2008.

S. Khemais-benkhiat, Angiotensin II-induced redox-sensitive SGLT1 and 2 expression promotes high glucose-induced endothelial cell senescence, Journal of cellular and molecular medicine, vol.109, issue.2, p.461, 2019.
URL : https://hal.archives-ouvertes.fr/hal-02322649

A. Kili?, Early and transient sodium-hydrogen exchanger isoform 1 inhibition attenuates subsequent cardiac hypertrophy and heart failure following coronary artery ligation, The Journal of pharmacology and experimental therapeutics, vol.351, issue.3, pp.492-499, 2014.

S. Kim and H. Iwao, Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases, Pharmacological reviews, vol.52, issue.1, pp.11-34, 2000.

G. Kimura, Importance of inhibiting sodium-glucose cotransporter and its compelling indication in type 2 diabetes: pathophysiological hypothesis, Journal of the American Society of Hypertension : JASH, vol.10, issue.3, pp.271-278, 2016.

S. Kinlay and P. Ganz, Role of Endothelial Dysfunction in Coronary Artery Disease and Implications for Therapy, The American Journal of Cardiology, vol.80, issue.9, pp.11-16, 1997.

Y. Y. Kisanuki, Low blood pressure in endothelial cell-specific endothelin 1 knockout mice, Hypertension, vol.56, issue.1, pp.121-128, 1979.

K. Kjeldsen, Diabetes decreases Na+-K+ pump concentration in skeletal muscles, heart ventricular muscle, and peripheral nerves of rat, Diabetes, vol.36, issue.7, pp.842-848, 1987.

T. Kobayashi and S. Narumiya, Function of prostanoid receptors: studies on knockout mice, Prostaglandins & other lipid mediators, pp.557-573, 2002.

K. K. Koh, Pleiotropic effects of angiotensin II receptor blocker in hypertensive patients, Journal of the American College of Cardiology, vol.42, issue.5, pp.905-910, 2003.

A. Kolakovic, M. Zivkovic, and A. Stankovic, Involvement of the Renin-Angiotensin System in Atherosclerosis, 2017.

M. Z. Koltai, Characteristics of coronary endothelial dysfunction in experimental diabetes, Cardiovascular research, vol.34, issue.1, pp.157-163, 1997.

M. Kosiborod, Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular, p.208, 2017.

, Users of Sodium-Glucose Cotransporter-2 Inhibitors), Circulation ?, vol.136, issue.3, pp.249-259

R. Kranzhöfer, Angiotensin induces inflammatory activation of human vascular smooth muscle cells. Arteriosclerosis, thrombosis, and vascular biology, vol.19, pp.1623-1629, 1999.

P. Kubes, M. Suzuki, and D. N. Granger, Nitric oxide: an endogenous modulator of leukocyte adhesion, Proceedings of the National Academy of Sciences, vol.88, issue.11, pp.4651-4655, 1991.

P. J. Kuhlencordt, Accelerated atherosclerosis, aortic aneurysm formation, and ischemic heart disease in apolipoprotein E/endothelial nitric oxide synthase double-knockout mice, Circulation ?, vol.104, issue.4, pp.448-454, 2001.

A. Kumar, p53 impairs endothelial function by transcriptionally repressing Kruppel-Like Factor 2. Arteriosclerosis, thrombosis, and vascular biology, vol.31, pp.133-141, 2011.

C. Kunsch and R. M. Medford, Oxidative stress as a regulator of gene expression in the vasculature, Circulation research, vol.85, issue.8, pp.753-766, 1999.

H. Kusaka, Empagliflozin lessened cardiac injury and reduced visceral adipocyte hypertrophy in prediabetic rats with metabolic syndrome, Cardiovascular diabetology, vol.15, issue.1, p.157, 2016.

K. Kusumoto, J. V. Haist, and M. Karmazyn, Na(+)/H(+) exchange inhibition reduces hypertrophy and heart failure after myocardial infarction in rats, American journal of physiology. Heart and circulatory physiology, vol.280, issue.2, pp.738-783, 2001.

G. J. Lagaud, Influence of type II diabetes on arterial tone and endothelial function in murine mesenteric resistance arteries, Journal of vascular research, vol.38, issue.6, pp.578-589, 2001.

S. Lahnwong, S. C. Chattipakorn, and N. Chattipakorn, Potential mechanisms responsible for cardioprotective effects of sodium-glucose co-transporter 2 inhibitors, Cardiovascular diabetology, vol.17, issue.1, p.101, 2018.

R. Lambert, Intracellular Na+ Concentration ([Na+]i) Is Elevated in Diabetic Hearts Due to Enhanced Na+-Glucose Cotransport, Journal of the American Heart Association, vol.4, issue.9, p.2183, 2015.

U. Landmesser and D. G. Harrison, Oxidant stress as a marker for cardiovascular events: Ox marks the spot, Circulation ?, vol.104, issue.22, pp.2638-2640, 2001.

U. Landmesser, Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension, The Journal of clinical investigation, vol.111, issue.8, pp.1201-1209, 2003.

G. L. Larson, The synthesis of gliflozins, Oligos Peptides, vol.33, issue.2, pp.37-40, 2015.

J. B. Laursen, Endothelial regulation of vasomotion in apoE-deficient mice: implications for interactions between peroxynitrite and tetrahydrobiopterin, Circulation ?, vol.103, issue.9, pp.1282-1288, 2001.

J. Lee, An ethanolic extract of Lindera obtusiloba stems causes NO-mediated endothelium-dependent relaxations in rat aortic rings and prevents angiotensin II-induced hypertension and endothelial dysfunction in rats. Naunyn-Schmiedeberg's archives of pharmacology, vol.383, pp.635-645, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00666997

J. Lee, An ethanolic extract of Lindera obtusiloba stems, YJP-14, improves endothelial dysfunction, metabolic parameters and physical performance in diabetic db/db mice, PloS one, vol.8, issue.6, p.65227, 2013.
URL : https://hal.archives-ouvertes.fr/hal-00841251

J. F. Leeuwenberg, E-selectin and intercellular adhesion molecule-1 are released by activated human endothelial cells in vitro, Immunology, vol.77, issue.4, pp.543-549, 1992.

A. F. Leite-moreira, Angiotensin II acutely decreases myocardial stiffness: a novel AT1, PKC and Na+/H+ exchanger-mediated effect, British journal of pharmacology, vol.147, issue.6, pp.690-697, 2006.

C. A. Lemarié and E. L. Schiffrin, The angiotensin II type 2 receptor in cardiovascular disease, Journal of the renin-angiotensin-aldosterone system, vol.11, issue.1, pp.19-31, 2010.

A. Lerman and J. C. Burnett, Intact and altered endothelium in regulation of vasomotion, Circulation ?, vol.86, issue.6, pp.12-19, 1992.

D. Levy, The progression from hypertension to congestive heart failure, JAMA, vol.275, issue.20, pp.1557-1562, 1996.

C. Li, Phlorizin Exerts Direct Protective Effects on Palmitic Acid (PA)-Induced Endothelial Dysfunction by Activating the PI3K/AKT/eNOS Signaling Pathway and Increasing the Levels of Nitric Oxide (NO), Medical Science Monitor Basic Research, vol.24, pp.1-9, 2018.

D. Y. Li, Upregulation of endothelial receptor for oxidized low-density lipoprotein (LOX-1) in cultured human coronary artery endothelial cells by angiotensin II type 1 receptor activation, Circulation research, vol.84, issue.9, pp.1043-1049, 1999.

S. Li, Distinct roles for the small GTPases Cdc42 and Rho in endothelial responses to shear stress, The Journal of clinical investigation, vol.103, issue.8, pp.1141-1150, 1999.

S. Li, Fluid shear stress activation of focal adhesion kinase. Linking to mitogen-activated protein kinases, Journal of Biological Chemistry, vol.272, issue.48, pp.30455-30462, 1997.

G. Liu, High sodium augments angiotensin II-induced vascular smooth muscle cell proliferation through the ERK 1/2-dependent pathway. Hypertension research : official journal of the, vol.37, pp.13-18, 2014.

W. E. Louch, Sodium accumulation promotes diastolic dysfunction in end-stage heart failure following Serca2 knockout, The Journal of physiology, vol.588, pp.465-478, 2010.

M. Luo, Diabetes increases mortality after myocardial infarction by oxidizing CaMKII, The Journal of clinical investigation, vol.123, issue.3, pp.1262-1274, 2013.

T. F. Luscher and M. Barton, Biology of the endothelium, Clinical cardiology, vol.20, issue.11, pp.3-10, 1997.

S. C. Lütken, Changes of renal AQP2, ENaC, and NHE3 in experimentally induced heart failure: response to angiotensin II AT1 receptor blockade, American journal of physiology. Renal physiology, vol.297, issue.6, pp.1678-88, 2009.

C. Maack, Elevated cytosolic Na+ decreases mitochondrial Ca2+ uptake during excitation-contraction coupling and impairs energetic adaptation in cardiac myocytes, Circulation research, vol.99, issue.2, pp.172-182, 2006.

A. M. Malek, S. L. Alper, and S. Izumo, Hemodynamic shear stress and its role in atherosclerosis, JAMA, vol.282, issue.21, pp.2035-2042, 1999.

S. J. Mancini, Canagliflozin inhibits interleukin-1?-stimulated cytokine and chemokine secretion in vascular endothelial cells by AMP-activated protein kinase-dependent and -independent mechanisms, Scientific reports, vol.8, issue.1, p.5276, 2018.

E. N. Marieb, Human Anatomy & Physiology, 2004.

D. S. Marks, Inhibition of neointimal proliferation in rabbits after vascular injury by a single treatment with a protein adduct of nitric oxide, The Journal of clinical investigation, vol.96, issue.6, pp.2630-2638, 1995.

N. Marui, Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells, The Journal of clinical investigation, vol.92, issue.4, pp.1866-1874, 1993.

A. Masumoto, Effect of pravastatin on endothelial function in patients with coronary artery disease (cholesterol-independent effect of pravastatin), The American Journal of Cardiology, vol.88, issue.11, pp.1291-1294, 2001.

S. F. Mause and C. Weber, Microparticles: protagonists of a novel communication network for intercellular information exchange, Circulation research, vol.107, issue.9, pp.1047-1057, 2010.

J. G. Mccormack, A. P. Halestrap, and R. M. Denton, Role of calcium ions in regulation of mammalian intramitochondrial metabolism, Physiological Reviews, vol.70, issue.2, pp.391-425, 1990.

J. Mcmurray, EMPA-REG -the "diuretic hypothesis, Journal of diabetes and its complications, vol.30, issue.1, pp.3-4, 2016.

D. R. Meeking, Effects of cyclo-oxygenase inhibition on vasodilatory response to acetylcholine in patients with type 1 diabetes and nondiabetic subjects, Diabetes care, vol.23, issue.12, pp.1840-1843, 2000.

P. K. Mehta and K. K. Griendling, Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system, AJP: Cell Physiology, vol.292, issue.1, pp.82-97, 2007.

R. M. Mentzer, Sodium-hydrogen exchange inhibition by cariporide to reduce the risk of ischemic cardiac events in patients undergoing coronary artery bypass grafting: results of the EXPEDITION study. The Annals of thoracic surgery, vol.85, pp.1261-1270, 2008.

V. Mering and J. , Ueber kunstlichen diabetes, Centralbl Med Wiss, p.531, 1886.

T. Minamino, Endothelial cell senescence in human atherosclerosis: role of telomere in endothelial dysfunction, Circulation ?, issue.13, pp.1541-1544, 2002.

R. D. Minshall and A. B. Malik, Transport across the endothelium: regulation of endothelial permeability, Handbook of experimental pharmacology, issue.176, pp.107-144, 2006.

H. Miura, Y. Liu, and D. D. Gutterman, Human coronary arteriolar dilation to bradykinin depends on membrane hyperpolarization: contribution of nitric oxide and Ca2+-activated K+ channels, Circulation ?, issue.24, pp.3132-3138, 1999.

Y. Miyazaki, High shear stress can initiate both platelet aggregation and shedding of procoagulant containing microparticles, Blood, vol.88, issue.9, pp.3456-3464, 1996.

S. Moncada and J. R. Vane, Arachidonic Acid Metabolites and the Interactions between Platelets and Blood-Vessel Walls, N Engl J Med, vol.300, issue.20, pp.1142-1147, 1979.

A. C. Montezano, Angiotensin II and Vascular Injury, Current Hypertension Reports, vol.16, issue.6, pp.435-446, 2014.

N. A. Mordi, Renal and Cardiovascular Effects of sodium-glucose cotransporter 2 (SGLT2) inhibition in combination with loop Diuretics in diabetic patients with Chronic Heart Failure (RECEDE-CHF): protocol for a randomised controlled double-blind cross-over trial, BMJ open, vol.7, issue.10, p.18097, 2017.

H. A. Mostefai, Phosphatidylinositol 3-Kinase and Xanthine Oxidase Regulate Nitric Oxide and Reactive Oxygen Species Productions by Apoptotic Lymphocyte Microparticles in Endothelial Cells, The Journal of Immunology, vol.180, issue.7, pp.5028-5035, 2008.

, Multiple Risk Factor Intervention Trial: Risk Factor Changes and Mortality Results, JAMA, vol.248, issue.12, pp.1465-1477, 1982.

E. Murphy and D. A. Eisner, Regulation of intracellular and mitochondrial sodium in health and disease, Circulation research, vol.104, issue.3, pp.292-303, 2009.

C. Nacci, Endothelial dysfunction in mice with streptozotocin-induced type 1 diabetes is opposed by compensatory overexpression of cyclooxygenase-2 in the vasculature, Endocrinology, vol.150, issue.2, pp.849-861, 2009.

T. Nagel, Shear stress selectively upregulates intercellular adhesion molecule-1 expression in cultured human vascular endothelial cells, The Journal of clinical investigation, vol.94, issue.2, pp.885-891, 1994.

Y. Nakashima, ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree, vol.14, pp.133-140, 1994.

Y. Nakashima, Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse. Arteriosclerosis, thrombosis, and vascular biology, vol.18, pp.842-851, 1998.

K. Naruse and M. Sokabe, Involvement of stretch-activated ion channels in Ca2+ mobilization to mechanical stretch in endothelial cells, The American journal of physiology, vol.264, issue.4, pp.1037-1081, 1993.

F. Naznin, Canagliflozin, a sodium glucose cotransporter 2 inhibitor, attenuates obesity-induced inflammation in the nodose ganglion, hypothalamus, and skeletal muscle of mice, European journal of pharmacology, vol.794, pp.37-44, 2017.

B. Neal, Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes, N Engl J Med, vol.377, issue.7, pp.644-657, 2017.

S. Neef, CaMKII-dependent diastolic SR Ca2+ leak and elevated diastolic Ca2+ levels in right atrial myocardium of patients with atrial fibrillation, Circulation research, vol.106, issue.6, pp.1134-1144, 2010.

S. Nicosia, PGI2 receptors in vasculature and platelets: 5Z-carbacyclin discriminates between them, Advances in prostaglandin, thromboxane, and leukotriene research, vol.17, pp.474-478, 1987.

Z. Nong, Nitric oxide inhalation inhibits platelet aggregation and platelet-mediated pulmonary thrombosis in rats, Circulation research, vol.81, issue.5, pp.865-869, 1997.

M. Oelze, The Sodium-Glucose Co-Transporter 2 Inhibitor Empagliflozin Improves Diabetes-Induced Vascular Dysfunction in the Streptozotocin Diabetes Rat Model by Interfering with Oxidative Stress and Glucotoxicity A. Cignarella, PloS one, vol.9, issue.11, pp.112394-112408, 2014.

Y. Ohashi, Hypotension and reduced nitric oxide-elicited vasorelaxation in transgenic mice overexpressing endothelial nitric oxide synthase, The Journal of clinical investigation, vol.102, issue.12, pp.2061-2071, 1998.

S. P. Olesen, D. E. Clapham, and P. F. Davies, Haemodynamic shear stress activates a K+ current in vascular endothelial cells, Nature, vol.331, issue.6152, pp.168-170, 1988.

M. Osawa, Tyrosine phosphorylation of platelet endothelial cell adhesion molecule-1 (PECAM-1, CD31) in mechanically stimulated vascular endothelial cells, European journal of cell biology, vol.72, issue.3, pp.229-237, 1997.

H. Osorio, Effect of phlorizin on SGLT2 expression in the kidney of diabetic rats, Journal of nephrology, vol.23, issue.5, pp.541-546, 2010.

H. Osorio, Effect of treatment with losartan on salt sensitivity and SGLT2 expression in hypertensive diabetic rats, Diabetes research and clinical practice, vol.86, issue.3, pp.46-55, 2009.

H. Ota, Cilostazol inhibits oxidative stress-induced premature senescence via upregulation of Sirt1 in human endothelial cells. Arteriosclerosis, thrombosis, and vascular biology, vol.28, pp.1634-1639, 2008.

A. P. Owens and N. Mackman, Microparticles in hemostasis and thrombosis, Circulation research, vol.108, issue.10, pp.1284-1297, 2011.

M. Packer, Activation and Inhibition of Sodium-Hydrogen Exchanger Is a Mechanism That Links the Pathophysiology and Treatment of Diabetes Mellitus With That of Heart Failure, Circulation ?, vol.136, issue.16, pp.1548-1559, 2017.

R. M. Palmer, D. S. Ashton, and S. Moncada, Vascular endothelial cells synthesize nitric oxide from L-arginine, Nature, vol.333, issue.6174, pp.664-666, 1988.

R. M. Palmer, A. G. Ferrige, and S. Moncada, Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor, Nature, vol.327, issue.6122, pp.524-526, 1987.

G. Paolisso and D. Giugliano, Oxidative stress and insulin action: is there a relationship?, Diabetologia, vol.39, issue.3, pp.357-363, 1996.

J. B. Park, F. Charbonneau, and E. L. Schiffrin, Correlation of endothelial function in large and small arteries in human essential hypertension, Journal of hypertension, vol.19, issue.3, pp.415-420, 2001.

K. Park and W. J. Park, Endothelial Dysfunction: Clinical Implications in Cardiovascular Disease and Therapeutic Approaches, Journal of Korean medical science, vol.30, issue.9, pp.1213-1225, 2015.

W. J. Paulus and C. Tschöpe, A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation, Journal of the American College of Cardiology, vol.62, issue.4, pp.263-271, 2013.

C. Petersen, Analyse des Phloridzins, Annalen der Pharmacie, vol.15, issue.2, pp.178-178, 1835.

R. Popp, A transferable, beta-naphthoflavone-inducible, hyperpolarizing factor is synthesized by native and cultured porcine coronary endothelial cells, The Journal of physiology, vol.497, pp.699-709, 1996.

R. Popp, I. Fleming, and R. Busse, Pulsatile stretch in coronary arteries elicits release of endothelium-derived hyperpolarizing factor: a modulator of arterial compliance, Circulation research, vol.82, issue.6, pp.696-703, 1998.

C. M. Potter, Role of shear stress in endothelial cell morphology and expression of cyclooxygenase isoforms. Arteriosclerosis, thrombosis, and vascular biology, vol.31, pp.384-391, 2011.

M. E. Pueyo, Angiotensin II stimulates endothelial vascular cell adhesion molecule-1 via nuclear factor-kappaB activation induced by intracellular oxidative stress, 2000.

T. Arteriosclerosis, , vol.20, pp.645-651

J. Quilley and J. C. Mcgiff, Is EDHF an epoxyeicosatrienoic acid? Trends in pharmacological sciences, vol.21, pp.121-124, 2000.

H. Rahmoune, Glucose Transporters in Human Renal Proximal Tubular Cells Isolated From the Urine of Patients With Non-Insulin-Dependent Diabetes, Diabetes, vol.54, issue.12, pp.3427-3434, 2005.

S. Rajagopalan, Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation, 1996.

, Contribution to alterations of vasomotor tone, The Journal of clinical investigation, vol.97, issue.8, pp.1916-1923

M. Ramratnam, Transgenic knockdown of cardiac sodium/glucose cotransporter 1 (SGLT1) attenuates PRKAG2 cardiomyopathy, whereas transgenic overexpression of cardiac SGLT1 causes pathologic hypertrophy and dysfunction in mice, Journal of the American Heart Association, vol.3, issue.4, p.9180, 2014.

I. Raz, DECLARE-TIMI 58: Participants' baseline characteristics. Diabetes, obesity & metabolism, vol.20, pp.1102-1110, 2018.

N. Resnick, Platelet-derived growth factor B chain promoter contains a cis-acting fluid shear-stress-responsive element, Proceedings of the National Academy of Sciences, vol.90, issue.16, p.7908, 1993.

G. M. Rodgers, Hemostatic properties of normal and perturbed vascular cells, FASEB journal : official publication of the Federation of American Societies for Experimental Biology, vol.2, issue.2, pp.116-123, 1988.

F. Rodier and J. Campisi, Four faces of cellular senescence, The Journal of cell biology, vol.192, issue.4, pp.547-556, 2011.

M. Rosolowsky and W. B. Campbell, Synthesis of hydroxyeicosatetraenoic (HETEs) and epoxyeicosatrienoic acids (EETs) by cultured bovine coronary artery endothelial cells, Biochimica et biophysica acta, vol.1299, issue.2, pp.267-277, 1996.

L. Rossetti, Correction of hyperglycemia with phlorizin normalizes tissue sensitivity to insulin in diabetic rats, The Journal of clinical investigation, vol.79, issue.5, pp.1510-1515, 1987.

J. C. Russell, Insulin-sensitizing and cardiovascular effects of the sodium-hydrogen exchange inhibitor, cariporide, in the JCR: LA-cp rat and db/db mouse, Journal of cardiovascular pharmacology, vol.46, issue.6, pp.746-753, 2005.

T. Sakurai, Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor, Nature, vol.348, issue.6303, pp.732-735, 1990.

H. M. Salim, Glycemic Control with Ipragliflozin, a Novel Selective SGLT2, 2016.

. Inhibitor, Ameliorated Endothelial Dysfunction in Streptozotocin-Induced Diabetic Mouse, Frontiers in cardiovascular medicine, vol.3, p.43

R. Sampath, Shear stress-mediated changes in the expression of leukocyte adhesion receptors on human umbilical vein endothelial cells in vitro, Annals of biomedical engineering, vol.23, issue.3, pp.247-256, 1995.

S. Sandmann, Differential effects of angiotensin AT1 and AT2 receptors on the expression, translation and function of the Na+-H+ exchanger and Na+-HCO3-symporter in the rat heart after myocardial infarction, Journal of the American College of Cardiology, vol.37, issue.8, pp.2154-2165, 2001.

S. L. Sandow and C. E. Hill, Incidence of myoendothelial gap junctions in the proximal and distal mesenteric arteries of the rat is suggestive of a role in endothelium-derived hyperpolarizing factor-mediated responses, Circulation research, vol.86, issue.3, pp.341-346, 2000.

M. Sarigianni, Involvement of signaling molecules on na/h exchanger-1 activity in human monocytes. The open cardiovascular medicine journal, vol.4, pp.181-188, 2010.

T. Sasahara, Na(+)/H(+) exchanger inhibitor induces vasorelaxation through nitric oxide production in endothelial cells via intracellular acidification-associated Ca2(+) mobilization, Vascular pharmacology, vol.58, issue.4, pp.319-325, 2013.

S. Sasaki, A low-calorie diet improves endothelium-dependent vasodilation in obese patients with essential hypertension, American journal of hypertension, vol.15, issue.4, pp.302-309, 2002.

A. Sánchez, Enhanced cyclooxygenase 2-mediated vasorelaxation in coronary arteries from insulin-resistant obese Zucker rats, Atherosclerosis, vol.213, issue.2, pp.392-399, 2010.

V. Schächinger, M. B. Britten, and A. M. Zeiher, Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease, Circulation ?, vol.101, issue.16, pp.1899-1906, 2000.

E. L. Schiffrin, Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan, Circulation ?, vol.101, issue.14, pp.1653-1659, 2000.

E. L. Schiffrin, F. S. Thomé, and J. Genest, Vascular angiotensin II receptors in renal and DOCA-salt hypertensive rats, Hypertension, vol.5, issue.6, pp.16-21, 1979.

A. M. Schmidt, Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the 222 accelerated vasculopathy of diabetes, The Journal of clinical investigation, vol.96, issue.3, pp.1395-1403, 1995.

K. M. Schmidt-ott, S. Kagiyama, and M. I. Phillips, The multiple actions of angiotensin II in atherosclerosis, Regulatory peptides, vol.93, issue.1-3, pp.65-77, 2000.

R. H. Schwinger, Reduced sodium pump alpha1, alpha3, and beta1-isoform protein levels and Na+,K+-ATPase activity but unchanged Na+-Ca2+ exchanger protein levels in human heart failure, Circulation ?, issue.16, pp.2105-2112, 1999.

S. O. Semb, Reduced myocardial Na+, K(+)-pump capacity in congestive heart failure following myocardial infarction in rats, Journal of Molecular and Cellular Cardiology, vol.30, issue.7, pp.1311-1328, 1998.

S. Senbanerjee, KLF2 Is a novel transcriptional regulator of endothelial proinflammatory activation, The Journal of experimental medicine, vol.199, issue.10, pp.1305-1315, 2004.

W. C. Sessa, The biosynthesis of endothelin-1 by human polymorphonuclear leukocytes, Biochemical and biophysical research communications, vol.174, issue.2, pp.613-618, 1991.

A. Sharma, Oxidative Stress and NLRP3-Inflammasome Activity as Significant Drivers of Diabetic Cardiovascular Complications: Therapeutic Implications, Frontiers in physiology, vol.9, p.114, 2018.

X. Shi, Effect of empagliflozin on cardiac biomarkers in a zebrafish model of heart failure: clues to the EMPA-REG OUTCOME trial? Molecular and cellular biochemistry, vol.433, pp.97-102, 2017.

P. J. Sims, Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane. Studies in Scott syndrome: an isolated defect in platelet procoagulant activity, Journal of Biological Chemistry, vol.264, issue.29, pp.17049-17057, 1989.

S. Spiekermann, Electron spin resonance characterization of vascular xanthine and NAD(P)H oxidase activity in patients with coronary artery disease: relation to endothelium-dependent vasodilation, Circulation ?, vol.107, issue.10, pp.1383-1389, 2003.

J. Stamler, J. D. Neaton, and D. N. Wentworth, Blood pressure (systolic and diastolic) and risk of fatal coronary heart disease, Hypertension, vol.13, issue.5, pp.2-12, 1979.

S. Steven, The SGLT2 inhibitor empagliflozin improves the primary diabetic complications in ZDF rats, Redox biology, vol.13, pp.370-385, 2017.

D. Sun, Enhanced release of prostaglandins contributes to flow-induced arteriolar dilation in eNOS knockout mice, Circulation research, vol.85, issue.3, pp.288-293, 1999.

M. Sundaresan, Requirement for generation of H2O2 for platelet-derived growth factor signal transduction, Science, issue.5234, pp.296-299, 1995.

C. Sunggip, N. Kitajima, and M. Nishida, Redox control of cardiovascular homeostasis by angiotensin II, Current pharmaceutical design, vol.19, issue.17, pp.3022-3032, 2013.

J. Suo, Hemodynamic shear stresses in mouse aortas: implications for atherogenesis. Arteriosclerosis, thrombosis, and vascular biology, vol.27, pp.346-351, 2007.

F. Swift, Altered Na+/Ca2+-exchanger activity due to downregulation of Na+/K+-ATPase alpha2-isoform in heart failure, Cardiovascular research, vol.78, issue.1, pp.71-78, 2008.

T. Szerafin, Increased cyclooxygenase-2 expression and prostaglandin-mediated dilation in coronary arterioles of patients with diabetes mellitus, Circulation research, vol.99, issue.5, pp.12-19, 2006.

N. M. Tabatabai, Enhanced expressions of sodium-glucose cotransporters in the kidneys of diabetic Zucker rats, Diabetes research and clinical practice, vol.83, issue.1, pp.27-30, 2009.

S. Taddei, Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension, Circulation ?, issue.22, pp.2222-2229, 1998.

E. H. Tang and P. M. Vanhoutte, Gene expression changes of prostanoid synthases in endothelial cells and prostanoid receptors in vascular smooth muscle cells caused by aging and hypertension, Physiological genomics, vol.32, issue.3, pp.409-418, 2008.

B. Telejko, Platelet sodium-proton exchanger and phospholipid-dependent procoagulant activity in patients with type 2 diabetes, Metabolism: clinical and experimental, vol.52, issue.1, pp.102-106, 2003.

N. Terami, Long-term treatment with the sodium glucose cotransporter 2 inhibitor, dapagliflozin, ameliorates glucose homeostasis and diabetic nephropathy in db/db mice, PloS one, vol.9, issue.6, p.100777, 2014.

M. E. Tushuizen, Cell-derived microparticles in the pathogenesis of cardiovascular disease: friend or foe? Arteriosclerosis, thrombosis, and vascular biology, vol.31, pp.4-9, 2011.

E. Tzima, Role of small GTPases in endothelial cytoskeletal dynamics and the shear stress response, Circulation research, vol.98, issue.2, pp.176-185, 2006.

E. Tzima, Activation of integrins in endothelial cells by fluid shear stress mediates Rho-dependent cytoskeletal alignment, The EMBO journal, vol.20, issue.17, pp.4639-4647, 2001.

E. Tzima, Activation of Rac1 by shear stress in endothelial cells mediates both cytoskeletal reorganization and effects on gene expression, The EMBO journal, vol.21, issue.24, pp.6791-6800, 2002.

E. Tzima, Localized cdc42 activation, detected using a novel assay, mediates microtubule organizing center positioning in endothelial cells in response to fluid shear stress, Journal of Biological Chemistry, vol.278, issue.33, pp.31020-31023, 2003.

M. Ushio-fukai, Novel role of gp91phox-containing NAD (P) H oxidase in vascular endothelial growth factor-induced signaling and angiogenesis, 2002.

L. Uthman, Class effects of SGLT2 inhibitors in mouse cardiomyocytes and hearts: inhibition of Na+/H+ exchanger, lowering of cytosolic Na+ and vasodilation, 2018.

, Diabetologia, vol.61, issue.3, pp.722-726

G. Valen, Z. Q. Yan, and G. K. Hansson, Nuclear factor kappa-B and the heart, Journal of the American College of Cardiology, vol.38, issue.2, pp.307-314, 2001.

E. D. Van-deel, In vitro model to study the effects of matrix stiffening on Ca2+ handling and myofilament function in isolated adult rat cardiomyocytes, The Journal of physiology, vol.595, issue.14, pp.4597-4610, 2017.

A. Van-steenbergen, Sodium-myoinositol cotransporter-1, SMIT1, mediates the production of reactive oxygen species induced by hyperglycemia in the heart, Scientific reports, vol.7, issue.1, p.41166, 2017.

P. A. Vanderlaan, C. A. Reardon, and G. S. Getz, Site specificity of atherosclerosis: site-selective responses to atherosclerotic modulators. Arteriosclerosis, thrombosis, and vascular biology, vol.24, pp.12-22, 2004.

P. M. Vanhoutte and E. H. Tang, Endothelial dysfunction: a strategic target in the treatment of hypertension? Pflügers Archiv : European journal of physiology, vol.459, pp.995-1004, 2010.

E. Vasile, Differential expression of thymosin beta-10 by early passage and senescent vascular endothelium is modulated by VPF/VEGF: evidence for senescent endothelial cells in vivo at sites of atherosclerosis, FASEB journal : official publication of the Federation of American Societies for Experimental Biology, vol.15, issue.2, pp.458-466, 2001.

J. Vásquez-vivar, Altered tetrahydrobiopterin metabolism in atherosclerosis: implications for use of oxidized tetrahydrobiopterin analogues and thiol antioxidants, 2002.

T. Arteriosclerosis, , vol.22, pp.1655-1661

S. Vestri, Changes in sodium or glucose filtration rate modulate expression of glucose transporters in renal proximal tubular cells of rat, The Journal of membrane biology, vol.182, issue.2, pp.105-112, 2001.

G. Vial, Na+/H+ exchange inhibition with cariporide prevents alterations of coronary endothelial function in streptozotocin-induced diabetes, Molecular and cellular biochemistry, pp.93-102, 2008.
URL : https://hal.archives-ouvertes.fr/inserm-00388539

I. Vrhovac, Localizations of Na(+)-D-glucose cotransporters SGLT1 and SGLT2 in human kidney and of SGLT1 in human small intestine, liver, lung, and heart. Pflügers Archiv : European journal of physiology, vol.467, pp.1881-1898, 2015.

Z. Wan, Involvement of NLRP3 inflammasome in the impacts of sodium and potassium on insulin resistance in normotensive Asians, The British journal of nutrition, vol.119, issue.2, pp.228-237, 2018.

S. Wang, Na+/H+ exchanger is required for hyperglycaemia-induced endothelial dysfunction via calcium-dependent calpain, Cardiovascular research, vol.80, issue.2, pp.255-262, 2008.

C. M. Warboys, Disturbed flow promotes endothelial senescence via a p53-dependent pathway. Arteriosclerosis, thrombosis, and vascular biology, vol.34, pp.985-995, 2014.

A. Warnholtz, Increased NADH-oxidase-mediated superoxide production in the early stages of atherosclerosis: evidence for involvement of the renin-angiotensin system, Circulation ?, issue.15, pp.2027-2033, 1999.

M. P. Wautier, Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE, American journal of physiology. Endocrinology and metabolism, vol.280, issue.5, pp.685-94, 2001.

D. Weiss, J. J. Kools, and W. R. Taylor, Angiotensin II-induced hypertension accelerates the development of atherosclerosis in apoE-deficient mice, Circulation ?, vol.103, issue.3, pp.448-454, 2001.

N. Werner, Circulating CD31+/annexin V+ apoptotic microparticles correlate with coronary endothelial function in patients with coronary artery disease, 2006.

T. Arteriosclerosis, , vol.26, pp.112-116

C. R. White, Circulating plasma xanthine oxidase contributes to vascular dysfunction in hypercholesterolemic rabbits, Proceedings of the National Academy of Sciences, vol.93, issue.16, pp.8745-8749, 1996.

M. D. Widmann, Cytochrome P-450 pathway in acetylcholine-induced canine coronary microvascular vasodilation in vivo, The American journal of physiology, vol.274, issue.1, 1998.

J. T. Willerson, Systemic and local inflammation in patients with unstable atherosclerotic plaques, Progress in cardiovascular diseases, vol.44, issue.6, pp.469-478, 2002.

S. D. Wiviott, Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes, N Engl J Med, vol.380, issue.4, pp.347-357, 2019.

B. Wojciak-stothard and A. J. Ridley, Shear stress-induced endothelial cell polarization is mediated by Rho and Rac but not Cdc42 or PI 3-kinases, The Journal of cell biology, vol.161, issue.2, pp.429-439, 2003.

M. S. Wolin, Interactions of oxidants with vascular signaling systems. Arteriosclerosis, thrombosis, and vascular biology, vol.20, pp.1430-1442, 2000.

, World Health Organization, Global Report on Diabetes, 2016.

E. M. Wright, Glucose transport families SLC5 and SLC50. Molecular aspects of medicine, vol.34, pp.183-196, 2013.

E. M. Wright, Renal Na(+)-glucose cotransporters, American journal of physiology. Renal physiology, vol.280, issue.1, pp.10-18, 2001.

E. M. Wright and E. Turk, The sodium/glucose cotransport family SLC5. Pflügers Archiv : European journal of physiology, vol.447, pp.510-518, 2004.

E. M. Wright, B. A. Hirayama, and D. F. Loo, Active sugar transport in health and disease, Journal of internal medicine, vol.261, issue.1, pp.32-43, 2007.

S. Wu, Cariporide, a specific Na/H(+) exchanger 1 blocker, inhibits neointimal proliferation induced by advanced glycation end products in a balloon injury rat model, Pharmacology, vol.91, issue.3-4, pp.123-130, 2013.

S. Wu, Local Augmented Angiotensinogen Secreted from Apoptotic Vascular Endothelial Cells Is a Vital Mediator of Vascular Remodelling, PloS one, vol.10, issue.7, p.132583, 2015.

X. Xiao and D. G. Allen, The role of endogenous angiotensin II in ischaemia, reperfusion and preconditioning of the isolated rat heart. Pflügers Archiv : European journal of physiology, vol.445, pp.643-650, 2003.

M. Yanagisawa, A novel potent vasoconstrictor peptide produced by vascular endothelial cells, Nature, vol.332, issue.6163, pp.411-415, 1988.

Y. Ye, SGLT-2 Inhibition with Dapagliflozin Reduces the Activation of the Nlrp3/ASC Inflammasome and Attenuates the Development of Diabetic Cardiomyopathy 231, 2017.

, Further Augmentation of the Effects with Saxagliptin, a DPP4 Inhibitor, Cardiovascular drugs and therapy, vol.31, issue.2, pp.119-132

T. Yokoi, Apoptosis signal-regulating kinase 1 mediates cellular senescence induced by high glucose in endothelial cells, Diabetes, vol.55, issue.6, pp.1660-1665, 2006.

M. Yokono, SGLT2 selective inhibitor ipragliflozin reduces body fat mass by increasing fatty acid oxidation in high-fat diet-induced obese rats, European journal of pharmacology, vol.727, pp.66-74, 2014.

N. Yoshikawa, Shear-stress causes polarized change in cytoplasmic calcium concentration in human umbilical vein endothelial cells (HUVECs), Cell calcium, vol.22, issue.3, pp.189-194, 1997.

A. M. Zeiher, Endothelium-mediated coronary blood flow modulation in humans. Effects of age, atherosclerosis, hypercholesterolemia, and hypertension, The Journal of clinical investigation, vol.92, issue.2, pp.652-662, 1993.

L. Zhou, Human cardiomyocytes express high level of Na+/glucose cotransporter 1 (SGLT1), Journal of Cellular Biochemistry, vol.90, issue.2, pp.339-346, 2003.

B. Zinman, Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes, N Engl J Med, vol.373, issue.22, pp.2117-2128, 2015.